Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications
Neves, M. et al. (2019) ‘Exploring sialyl-TN expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for Precision Oncology Applications’, New Biotechnology, 49, pp. 77–87.
MassMEDIC, the Massachusetts Medical Device Industry Council, announced today the 2021 IGNITE Cohort, and RUBYnanomed was one of the awarded medtech startups. Press release: follow the link